🔎 Trials Near Me

Akèy › Kansè tete negatif triple › South Carolina › Charleston

Etid klinik pou Kansè tete negatif triple nan Charleston, SC

6 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

Ap rekriteFaz 2
  • Medical University of South Carolina Hollings Cancer Center,, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07743190

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ap rekriteFaz 1
  • Normunity Investigational Site, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

Ap rekriteFaz 2
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06845319

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Ap rekriteFaz 2
  • Medical University of South Carolina, Charleston
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT04468061

Etid Kansè tete negatif triple nan lòt vil

Lòt etid nan Charleston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.